Sectors:
Min Investment:
Max Investment:
Target Investment:
Postdoc
Ph.D.
(2021 - 2021)
(2022 - 2022)
2021
JJDC is the strategic corporate venture capital group for Johnson & Johnson; launched in 1973, it is one of the longest-running and most reputable CVC in health care. I cover investments in areas of strategic interest to Johnson & Johnson. In support of J&J strategic objectives, I work closely with Innovation Centers, JLabs, Therapeutic Areas, Business Development, Commercial, and R&D Functional Areas.
2023
2023
Circode develops novel RNA therapeutics for multiple disease areas
2022
DAC Biotechnology is an antibody-drug-conjugate (ADC) company that has established an end-to-end capability for ADC generation and an innovative pipeline in pre-clinical and clinical stages.
2021 - 2021
2021 - 2021
ImmPact Bio is pioneering a novel strategy to surmount a major challenge compromising current T-cell (CAR-T) therapy
2020 - 2021
2020 - 2021
Actym Therapeutics is developing a microbial-based immunotherapy platform for various challenging cancer types.
2019 - 2021
2019 - 2021
Illumina Ventures is an independently managed fund focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. We invest in life science tools, therapeutics, clinical diagnostics, and other opportunities to improve human health. My primary focus was on platform therapeutics related to genomics, synthetic biology, precision medicine, and new modalities. Covered investments: Actym Therapeutics, Kallyope, Encoded Therapeutics.
2019 - 2020
2019 - 2020
Immunotherapies for cancer
2017 - 2019
2017 - 2019
BOE Technology Group (https://www.boe.com/en/about/gsjs/), is a FORBES global2000 company headquartered in Beijing, China. BOE is a leader in semiconductor display technologies, products, manufacturing and services. BOE recently expands business into smart system and healthcare. BOE's healthcare investment focus on the intersection of high-tech and healthcare including: healthcare IoT, genomics, point-of-care diagnostics, medical device, consumer health, digital hospitals/care facilities, gene/cell therapy. BOE also seeks collaborations with investigators at universities/research institutes/hospitals through sponsored research to promote early-stage innovations in strategic interest areas. -Lead all aspects of sourcing and deal execution -Manage collaboration projects, investment portfolio, and LP-GP relationship -Recruitment, training, and team building -Corporate strategy, technology planning, and business development -PR/marketing/ecosystem expansion
2017 - 2019
2017 - 2019
Ceribell is focused on making EEG widely accessible, drastically more efficient, and more cost-effective to improve the diagnosis and treatment of neurological patients.
2017 - 2019
2017 - 2019
Baebies, guided by the vision that “everyone deserves a healthy start,” delivers innovative products and services for newborn screening and pediatric testing.